| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Revenue | $14.3M | +12.2% |
| Cost of Revenue | $8.8M | +10.4% |
| Gross Profit | $5.5M | +15.2% |
| R&D Expense | $1.8M | -3.0% |
| SG&A Expense | $7.4M | -2.8% |
| Operating Income | -$3.7M | +21.1% |
| Pre-tax Income | -$2.9M | +42.2% |
| Income Tax | $550K | +380.6% |
| Net Income | -$3.5M |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.4M | +71.8% |
| Accounts Receivable | $2.2M | -23.0% |
| Inventory | $2.9M | +7.2% |
| Current Assets | $12.6M | +0.8% |
| Total Assets | $13.7M | -7.1% |
| Current Liabilities | $4.1M | +10.1% |
| Total Liabilities | $9.3M | +7.9% |
| Line Item | 2025-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$88K | +96.3% |
| Capital Expenditures | $80K | +370.6% |
| Investing Cash Flow | -$80K | -3900.0% |
| Financing Cash Flow | $3.0M | +80.8% |
| Free Cash Flow | -$168K | +93.0% |
| +28.5% |
| EPS (Basic) | -$2.79 | -426.4% |
| EPS (Diluted) | -$2.79 | -426.4% |
| Stockholders' Equity |
| $4.4M |
| -28.1% |